Mostrando 1 - 3 resultados de 3 para a busca 'A. E. van Leeuwen', tempo de busca: 0.04s Refinar Resultados
  1. 1
    Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design

    Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design por A. Klaassen-Dekker, C. H. C. Drossaert, M. C. Van Maaren, A. E. Van Leeuwen-Stok, V. P. Retel, J. C. Korevaar, S. Siesling, on behalf of the NABOR project group

    Publicado em 2023-11-01
    Obter o texto integral
    Artigo
  2. 2
    Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade

    Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade por M. C. Liefaard, A. van der Voort, M. van Seijen, B. Thijssen, J. Sanders, S. Vonk, L. Mittempergher, R. Bhaskaran, L. de Munck, A. E. van Leeuwen-Stok, R. Salgado, H. M. Horlings, E. H. Lips, G. S. Sonke

    Publicado em 2024-04-01
    Obter o texto integral
    Artigo
  3. 3
    BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer

    BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer por M. C. Liefaard, A. van der Voort, M. S. van Ramshorst, J. Sanders, S. Vonk, H. M. Horlings, S. Siesling, L. de Munck, A. E. van Leeuwen, M. Kleijn, L. Mittempergher, M. M. Kuilman, A. M. Glas, J. Wesseling, E. H. Lips, G. S. Sonke

    Publicado em 2023-06-01
    Obter o texto integral
    Artigo

Ferramentas de busca: